RESULTS OF A CLINICAL-TRIAL IN HUMANS WITH REFRACTORY CANCER OF THE INTRACELLULAR HISTAMINE ANTAGONIST, DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE-HCL, IN COMBINATION WITH VARIOUS SINGLE ANTINEOPLASTIC AGENTS
Lj. Brandes et al., RESULTS OF A CLINICAL-TRIAL IN HUMANS WITH REFRACTORY CANCER OF THE INTRACELLULAR HISTAMINE ANTAGONIST, DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE-HCL, IN COMBINATION WITH VARIOUS SINGLE ANTINEOPLASTIC AGENTS, Journal of clinical oncology, 12(6), 1994, pp. 1281-1290